A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
Clinical trial NCT02020226 · UNKNOWN
Trial details
- NCT number
- NCT02020226
- Sponsor
- Threshold Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.